Weight-loss drugs could treat fatal heart attack complications, UK study finds
Latest research based on animal model trials shows GLP-1 drugs may prevent problem of ‘no-reflow’ in recoveryWeight-loss drugs could help people who have had a heart attack avoid suffering potentially fatal complications afterwards, research has found.Drugs such as Ozempic and Wegovy reduce the...
<p>Latest research based on animal model trials shows GLP-1 drugs may prevent problem of ‘no-reflow’ in recovery</p><p>Weight-loss drugs could help people who have had a heart attack avoid suffering potentially fatal complications afterwards, research has found.</p><p>Drugs such as Ozempic and Wegovy reduce the risk of the tissue damage that affects up to half of the 100,000 people a year in the UK who suffer a heart attack, according to the study.</p> <a href="https://www.theguardian.com/science/2026/mar/03/weight-loss-drugs-could-treat-fatal-heart-attack-complications-uk-study-finds">Continue reading...</a>
Read the full article at:
The Guardian World →